Y, Ge L, Zhao G, Liu C, Ma L. Extended non-coding RNAs as prognostic biomarkers in papillary renal cell carcinoma. Oncol Lett. 2019;18(4):3691. Tang R, Xu J, Zhang B, Liu J, Liang C, Hua J, Meng Q, Yu X, Shi S. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J Hematol Oncol. 2020;13(1):110. Song X, Extended D. Nrf2 and ferroptosis: a new analysis direction for neurodegenerative diseases. Front Neurosci. 2020;14:267. Chu B, Kon N, Chen D, Li T, Liu T, Jiang L, Song S, Tavana O, Gu W. ALOX12 is necessary for p53-mediated tumor suppression by means of a distinct ferroptosis pathway. Nat Cell Biol. 2019;21(5):5791. Jennis M, Kung CP, Basu S, Budina-Kolomets A, Leu JI, Khaku S, Scott JP, Cai KQ, Campbell MR, Porter DK, et al. An African-specific polymorphism within the TP53 gene impairs p53 tumor suppressor function within a mouse model. Genes Dev. 2016;30(eight):918-s930. Ou Y, Wang SJ, Li D, Chu B, Gu W. Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses. Proc Natl Acad Sci U S A. 2016;113(44):E68062. Lajko E, Hegedus R, Mezo G, Kohidai L. Apoptotic effects of drug targeting conjugates containing various GnRH analogs on colon cancer cells. Int J Mol Sci. 2019;20(18):4421.Publisher’s NoteSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Considering that January 2020 Elsevier has produced a COVID-19 resource centre with absolutely free information and facts in English and Mandarin around the novel coronavirus COVID19.STING-IN-5 Cancer The COVID-19 resource centre is hosted on Elsevier Connect, the company’s public news and information and facts web site.Elsevier hereby grants permission to make all its COVID-19-related investigation that is definitely readily available around the COVID-19 resource centre – which includes this study content material – straight away offered in PubMed Central and other publicly funded repositories, including the WHO COVID database with rights for unrestricted investigation re-use and analyses in any kind or by any means with acknowledgement of your original source. These permissions are granted for free by Elsevier for provided that the COVID-19 resource centre remains active.Received: 17 September 2021 Revised: 7 February 2022 Accepted: 7 February 2022 DOI: 10.1111/ajt.||CASE REPORTAJTSevere relapse of SARS-CoV-2 infection in a kidney transplant recipient with adverse nasopharyngeal SARS-CoV-2 RT-PCR right after rituximabAntoine Morel1,2| Sandrine Imbeaud3| Anne Scemla1,2| H e P | Jacques Fourgeaud4| Lucile Amrouche1,2 | Nicolas Robillard5| Delphine Planas6,7| Julien Puech5| Sylvie Simon8| Fanny Lanternier2,9| Laurent B ec5,10| Julien Zuber1,2 | Olivier Schwartz6,7| Dany Anglicheau1,2 | Nathalie Chavarot1,two | David Veyer3,1 two 3 4 5 6 7 8Department of Nephrology and Kidney Transplantation, Necker-Enfants Malades Hospital, Assistance Publique-H itaux de Paris, Paris, France Universitde Paris, Paris, France INSERM, Functional Genomics of Solid Tumors (FunGeST), Centre de Recherche des Cordeliers, Universitde Paris and Sorbonne Universit Paris, France Virology Laboratory, Necker Hospital, Help Publique-H itaux de Paris, Paris, France Virology Laboratory, Department of Microbiology, H ital Europ n Georges Pompidou, Assistance Publique-H itaux de Paris, Paris, France Virus Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, Paris, France Vaccine Analysis Institute, Creteil, France Department of Microbiology, H ital Europ n Georges Pompidou, Assistance Publique-H itaux de Paris, Paris, France Division of.Arbaclofen placarbil In Vitro PMID:24576999